Supresión de un paso terapéutico en el tratamiento de la hipertensión arterial severa

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Se reportan los resultados obtenidos con prazosin en 20 pacientes con hipertensión arterial severa en quienes la asociacion de multiples agentes antihipertensivos a dosis máximas no estaba produciendo adecuados efectos terapéuticos. Al incluir prazosin en el protocolo de tratamiento de dichos pacientes, se observaron resultados muy satisfactorios, hallándose en la actualidad sus cifras tensionales bajo control con 3 a 4 tabletas diarias, en vez de las 8 ó 10 que tomaban anteriormente. Se concluye que se debe incluir a prazosin en los esquemas terapéuticos antihipertensivos.

Related collections

Author and article information

Journal

Journal ID (publisher-id): CRD

Journal ID (nlm-ta): Cardiology

Journal ID (doi): 10.1159/issn.0008-6312

Title: Cardiology

Publisher: S. Karger AG

ISBN: 978-3-8055-1557-3

ISBN: 978-3-318-01519-5

ISSN (Print): 0008-6312

ISSN (Electronic): 1421-9751

Publication date Subscription-year: 1980

Publication date (Print): 1980

Publication date (Electronic): 07 November 2008

Volume: 66

Issue: Suppl 2

Pages: 82-84

Affiliations

Sección de Cardiologia, Escuela Colombiana de Medicina, Bogotá, Colombia

Article

Publisher ID: 173012 Other ID: Cardiology 1980;66:82–84

DOI: 10.1159/000173012

PubMed ID: 7285034

SO-VID: c3e476db-ad3e-4edd-9bc6-0e01a3431b67

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Supresión de un paso terapéutico en el tratamiento de la hipertensión arterial severa

Read this article at

Abstract

Related collections

Karger: Cardiovascular System

Author and article information

Journal

Affiliations

Article

History

Page count

Categories

Comments

Comment on this article

Similar content 329